Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004486 · ClinicalTrials.gov registry record · NA
Randomized Study of Fluoxetine in Children and Adolescents With Autism
A NA study of Autism, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 3
- Study locations
NCT00004486 is a NA study of Autism that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 45 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT00004486, a NA study of Autism, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 3
- Study locations
Study Summary
OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global severity and compulsive dimensions of children and adolescents with autism. II. Assess the effectiveness of this treatment regimen on neurocognitive deficits in this patient population. III. Compare the baseline compulsive severity and treatment outcome in these patients.
Conditions Studied
Interventions
- DRUG fluoxetine
Study Locations (3)
New York
- New York University Medical Center - New York
- Mount Sinai School of Medicine - New York
- Albert Einstein College of Medicine - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 1998-09 |
| Est. Completion | 2002-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004486
The ClinicalTrials.gov registry entry for NCT00004486 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (75% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which fluoxetine is the first listed.
NCT00004486 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00004486 about?
NCT00004486 is a clinical study titled "Randomized Study of Fluoxetine in Children and Adolescents With Autism". OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global severity and compulsive dimensions of children and adolescents with autism. II. Assess the effectiveness of this treatment regimen on neurocognitive deficits in this patient population. III. Compare the base...
What is the current status of trial NCT00004486?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 1998-09. Estimated completion is 2002-12.
What conditions does trial NCT00004486 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT00004486?
The interventions under investigation include: fluoxetine (DRUG).
Who is sponsoring clinical trial NCT00004486?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004486 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.